237 related articles for article (PubMed ID: 24793657)
1. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
2. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
[TBL] [Abstract][Full Text] [Related]
3. PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins.
Minardi S; Pandolfi L; Taraballi F; De Rosa E; Yazdi IK; Liu X; Ferrari M; Tasciotti E
ACS Appl Mater Interfaces; 2015 Aug; 7(30):16364-73. PubMed ID: 26108253
[TBL] [Abstract][Full Text] [Related]
4. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
6. A sustained dual drug delivery system for proliferative vitreoretinopathy.
Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
[TBL] [Abstract][Full Text] [Related]
7. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
[TBL] [Abstract][Full Text] [Related]
8. The comparative study of influence of lactic and glycolic acids copolymers type on properties of daunorubicin loaded nanoparticles and drug release.
Nikolskaya E; Sokol M; Faustova M; Zhunina O; Mollaev M; Yabbarov N; Tereshchenko O; Popov R; Severin E
Acta Bioeng Biomech; 2018; 20(1):65-77. PubMed ID: 29658530
[TBL] [Abstract][Full Text] [Related]
9. MBG/PLGA composite microspheres with prolonged drug release.
Li X; Wang X; Zhang L; Chen H; Shi J
J Biomed Mater Res B Appl Biomater; 2009 Apr; 89(1):148-54. PubMed ID: 18777577
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
11. Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.
Hong X; Wei L; Ma L; Chen Y; Liu Z; Yuan W
Int J Nanomedicine; 2013; 8():2433-41. PubMed ID: 23882140
[TBL] [Abstract][Full Text] [Related]
12. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
13. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
Sweet JL; Pillay V; Choonara YE
Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
15. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
16. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
Yang H; Li K; Liu Y; Liu Z; Miyoshi H
J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin.
Xue JM; Tan CH; Lukito D
J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):417-22. PubMed ID: 16470829
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
Jiang G; Qiu W; DeLuca PP
Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]